NCIt definition : An immunoglobulin G1 (IgG1) monoclonal antibody directed against the spike (S) protein
of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially
be used for immunization against the Coronavirus disease 2019 (COVID-19). Upon administration,
rimteravimab specifically targets and binds to the receptor-binding domain (RBD) of
the S protein, thereby blocking viral attachment and entry into human cells and may
thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate
recovery, and may potentially provide temporary protection against infection with
SARS-CoV-2.;
UNII : Z4LZB5VCU4;
CAS number : 2540797-21-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2540797-21-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Semantic type(s)